Check Out What Whales Are Doing With JNJ

Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades.

Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $170,500, and 6 were calls, valued at $475,867.

What's The Price Target?

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $140.0 to $165.0 for Johnson & Johnson over the recent three months.

Volume & Open Interest Development

In today's trading context, the average open interest for options of Johnson & Johnson stands at 3090.6, with a total volume reaching 1,270.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Johnson & Johnson, situated within the strike price corridor from $140.0 to $165.0, throughout the last 30 days.

Johnson & Johnson 30-Day Option Volume & Interest Snapshot

Significant Options Trades Detected:

About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

After a thorough review of the options trading surrounding Johnson & Johnson, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Johnson & Johnson's Current Market Status

• Currently trading with a volume of 453,018, the JNJ's price is up by 0.77%, now at $156.04.
• RSI readings suggest the stock is currently may be approaching overbought.
• Anticipated earnings release is in 32 days.

Expert Opinions on Johnson & Johnson

Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $175.5.

• In a positive move, an analyst from UBS has upgraded their rating to Buy and adjusted the price target to $180.
• In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $178.
• An analyst from RBC Capital persists with their Outperform rating on Johnson & Johnson, maintaining a target price of $181.
• An analyst from Wells Fargo has revised its rating downward to Equal-Weight, adjusting the price target to $163.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Johnson & Johnson with Benzinga Pro for real-time alerts.